JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, M. H.
Right arrow Articles by King, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, M. H.
Right arrow Articles by King, J. F.

The Journal of Thoracic and Cardiovascular Surgery, Vol 93, 56-61, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Risk factors among patients undergoing repeat aorta-coronary bypass procedures

MH Fox, HW Gruchow, JJ Barboriak, AJ Anderson, RG Hoffmann, RJ Flemma and JF King

It is estimated that as many as 7% of patients who have an aorta- coronary bypass operation will require a second bypass procedure within 10 to 12 years. Using information from the Milwaukee Cardiovascular Data Registry, we matched 166 men who underwent two coronary bypass operations at least 6 months apart, between 1968 and 1981, with 428 patients who had a single procedure. Patients were matched according to date of operation and left ventricular wall motility function for analysis of risk factors for repeat operation. Elevated triglyceride levels were found to be the strongest risk factors associated with reoperation. In addition, both younger age and less complete revascularization during the first operation were significant predictive factors of repeat operation. The results suggest that efforts to reduce plasma triglyceride levels and ensure adequate revascularization may significantly reduce the need for repeat coronary bypass.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. J. Domanski, C. B. Borkowf, L. Campeau, G. L. Knatterud, C. White, B. Hoogwerf, Y. Rosenberg, N. L. Geller, and the Post-CABG Trial Investigators
Prognostic factors for atherosclerosis progression in saphenous vein grafts: The postcoronary artery bypass graft (post-CABG) trial
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1877 - 1883.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. G. Motwani and E. J. Topol
Aortocoronary Saphenous Vein Graft Disease : Pathogenesis, Predisposition, and Prevention
Circulation, March 10, 1998; 97(9): 916 - 931.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. D. Mehta, J. Weinberg, M. F. Jones, G. Tellides, G. S. Kopf, R. K. Shaw, B. L. Zaret, and J. A. Elefteriades
Should Angiographically Disease-Free Saphenous Vein Grafts Be Replaced at the Time of Redo Coronary Artery Bypass Grafting?
Ann. Thorac. Surg., January 1, 1998; 65(1): 17 - 23.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. M. Grundy and G. L. Vega
Two Different Views of the Relationship of Hypertriglyceridemia to Coronary Heart Disease: Implications for Treatment
Arch Intern Med, January 1, 1992; 152(1): 28 - 34.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The American Association for Thoracic Surgery.